Skip to main content
American Journal of Physiology - Heart and Circulatory Physiology logoLink to American Journal of Physiology - Heart and Circulatory Physiology
. 2020 Apr 17;318(5):H1346–H1355. doi: 10.1152/ajpheart.00601.2019

Excessive dietary salt promotes aortic stiffness in murine renovascular hypertension

Leon J DeLalio 1, Scott Hahn 2, Pedro L Katayama 1, Megan M Wenner 3, William B Farquhar 3, Adam C Straub 2,4, Sean D Stocker 1,
PMCID: PMC7346535  PMID: 32302491

Abstract

Renovascular hypertension is characterized by activation of the renin-angiotensin-aldosterone system, blunted natriuretic responses, and elevated sympathetic nerve activity. Excess dietary salt intake exaggerates arterial blood pressure (ABP) in multiple models of experimental hypertension. The present study tested whether a high-salt diet exaggerated ABP and vascular dysfunction in a 2-kidney, 1-clip (2K1C) murine model. Male C57BL/6J mice (8–12 wk) were randomly assigned, and fed a 0.1% or 4.0% NaCl diet, and instrumented with telemetry units to measure ABP. Then, the 2K1C model was produced by placing a cuff around the right renal artery. Systolic, diastolic, and mean ABP were significantly higher in mice fed 4.0% vs. 0.1% NaCl at 1 wk but not after 3 wk. Interestingly, 2K1C hypertension progressively increased arterial pulse pressure in both groups; however, the magnitude was significantly greater in mice fed 4.0% vs. 0.1% NaCl at 3 wk. Moreover, pulse wave velocity was significantly greater in 2K1C mice fed 4.0% vs. 0.1% NaCl diet or sham-operated mice fed either diet. Histological assessment of aortas indicated no structural differences among groups. Finally, endothelium-dependent vasodilation was significantly and selectively attenuated in the aorta but not mesenteric arteries of 2K1C mice fed 4.0% NaCl vs. 0.1% NaCl or sham-operated control mice. The findings suggest that dietary salt loading transiently exaggerates 2K1C renovascular hypertension but promotes chronic aortic stiffness and selective aortic vascular dysfunction.

NEW & NOTEWORTHY High dietary salt exaggerates hypertension in multiple experimental models. Here we demonstrate that a high-salt diet produces a greater increase in arterial blood pressure at 1 wk after induction of 2-kidney, 1-clip (2K1C) hypertension but not at 3 wk. Interestingly, 2K1C mice fed a high-salt diet displayed an exaggerated pulse pressure, elevated pulse wave velocity, and reduced endothelium-dependent vasodilation of the aorta but not mesenteric arteries. These findings suggest that dietary salt may interact with underlying cardiovascular disease to promote selective vascular dysfunction and aortic stiffness.

Keywords: aortic stiffness, hypertension, 2K1C, salt sensitivity

INTRODUCTION

Renovascular hypertension is a common form of secondary hypertension that accounts for 2–5% of systemic hypertension and 24.0% of resistant hypertension (3, 9). Commonly, atherosclerotic lesions in one or both renal arteries engender renal hypoperfusion and ischemia (60). The resultant rise in arterial blood pressure (ABP) has been attributed to multiple factors including activation of the renin-angiotensin-aldosterone system (RAAS), renal dysfunction and blunted natriuresis, and elevated sympathetic outflow. The relative contribution of each mechanism may differ over time. For example, the early phase of 2-kidney, 1-clip (2K1C) hypertension is characterized by a robust activation of the RAAS (6, 49), and pharmacological or genetic inhibition of RAAS attenuates hypertension in 2K1C models (7, 36, 48). As 2K1C hypertension persists, a neurogenic-mediated increase in total peripheral resistance due to elevated sympathetic outflow also contributes to the elevated ABP (11, 24, 42). The mechanisms underlying the sympathoexcitation are unknown but attributed to the central action of systemic angiotensin II and activation of renal sensory nerves (32, 41).

Excess dietary salt intake is strongly correlated with cardiovascular disease and is regarded as a major contributing factor to the pathogenesis of hypertension (1, 61, 62). Multiple systems contribute to salt-sensitive hypertension including impaired renal and vascular function and the sympathetic nervous system (30, 43, 44, 55, 57). Experimentally, dietary salt loading has been repeatedly demonstrated to increase and exaggerate ABP in multiple experimental models including Dahl salt-sensitive rats (22, 38), deoxycorticosterone acetate-salt (23, 25), chronic infusion of angiotensin II (28), and reduced renal mass (18, 19, 21). In regard to 2K1C models of renovascular hypertension, the majority of studies report that a high-NaCl diet does not exaggerate ABP (10, 15, 35, 49, 51). However, these previous studies largely relied on tail-cuff measurements of ABP or ABP measurements at a single time point. A telemetry-based study using a 2K1C rat model reported no significant differences between 0.2% and 4.0% NaCl diets (35). However, the conclusion was based on a single 24-h systolic ABP value at 3 wk despite systolic values appearing greater in rats fed 4.0% versus 0.2% NaCl (188 mmHg vs. 162 mmHg, respectively). Furthermore, the time of dietary salt manipulation may represent another important factor. Previous studies (10, 15, 35, 49, 51) administered salt diets either at the time of renal artery clipping or after the establishment of hypertension rather than acclimating animals to the respective diet to mimic chronic dietary salt consumption in clinical populations.

The purpose of the present investigation was to evaluate the effects of dietary salt intake on 2K1C hypertension using mice chronically fed 0.1% or 4.0% NaCl diets and monitored with modern ABP telemetric approaches. Animals were fed the respective diets for 2 wk before clipping to produce a steady state and mimic chronic dietary pattern. We hypothesized that elevated ABP due to renal artery stenosis exhibits salt sensitivity, as dietary salt exacerbates several models of hypertension associated with similar characteristics. To assess hemodynamic changes, we assessed in vivo pulse pressure wave velocity (PWV) for aortic stiffness and measured vascular function from conduit and resistance arteries by myography.

MATERIALS AND METHODS

Animals.

All experimental procedures conform to the National Institutes of Health’s Guide for the Care and Use of Laboratory Animals and were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Male C57BL/6J mice (8–15 wk; Jackson Laboratories strain 00664) were housed in a temperature-controlled room (22 ± 1°C), given ad libitum access to deionized water, and randomly assigned to a 0.1% NaCl (Research Diets, D17020) or 4.0% NaCl (Research Diets, D17013) chow diet for 2 wk before experimentation.

2K1C model.

2K1C hypertension was produced with methods described previously (26, 41, 59). Mice were anesthetized with isoflurane (2–3% in 100% oxygen). Through a retroperitoneal incision, the right kidney was gently retracted and a small section of the renal artery isolated free from the renal vein and/or nerve. A 0.5-mm polytetrafluoroethylene (PTFE) catheter (ID: 0.008 × OD: 0.014; Braintree Scientific SUBL140) was cut longitudinally, placed around the renal artery distal to the adrenal artery, and secured with two 10-0 circumferential sutures around the catheter. Sham-operated control animals had the right renal artery isolated, but no cuff was implanted. All incisions were closed with suture, and animals were treated with Buprenex (0.03 mg/kg buprenorphine ip; 2 times per day for 48 h; Henry Schein) and Enroflox (2 mg/kg enrofloxacin ip; Norbrook Laboratories).

Experiment 1: Effect of dietary salt intake on 2K1C hypertension.

To assess the impact of a high-salt diet on 2K1C hypertension, male C57BL/6J mice (n = 8 per group) were singly housed and fed a 0.1% or 4.0% NaCl diet for at least 1 wk. Then, mice were anesthetized with isoflurane (2–3% in 100% oxygen) and instrumented with PA-C10 telemetry units (Data Science International) as described previously (41). The catheter tip advanced 1.5 cm into the femoral artery, and the transmitter body was inserted in the flank. Mice were treated with Buprenex (0.03 mg/kg ip; 2 times per day for 48 h) and enrofloxacin (2 mg/kg ip) and allowed to recover for 1 wk. Then, baseline ABP and heart rate were recorded for 4 days before and 21 days after induction of 2K1C hypertension. The raw ABP signal was sampled and digitized at 500 Hz with a Micro1401 and Spike2 software (CED). Data were analyzed beat to beat for systolic and diastolic ABP. Beat-to-beat pulse pressure was calculated by subtracting the diastolic pressure from the systolic pressure. Mean ABP was calculated by diastolic plus 1/3 pulse pressure. Daytime BP was measured from 10:00 am to 4:00 pm (lights on 7:00 am–7:00 pm), and nighttime BP was measured from 10:00 pm to 4:00 am (lights off 7:00 pm–7:00 am). Twenty-four-hour averages were calculated with daytime and nighttime values.

Experiment 2: Effect of dietary salt intake on PWV in 2K1C hypertension.

To assess aortic stiffness, beat-to-beat PWV was measured in a second group of 2K1C and sham-operated mice fed a 0.1% or 4.0% NaCl diet. Male C57BL/6J mice (n = 8 per group) were randomly assigned and fed 0.1% and 4.0% NaCl diets. Two weeks later, 2K1C or sham surgery was performed as described above, but telemetry units were not implanted. At 18–20 days after 2K1C or sham surgery, mice were anesthetized with isoflurane (1.8–2.5% in 100% oxygen). Body temperature was maintained at 37.0 ± 0.2°C through a servo-controlled temperature controller and rectal probe (CWE Inc.). A fluid-filled catheter (PE10 tubing; Braintree Scientific) was advanced 0.7 cm into the left common carotid artery, proximal to the bifurcation of the internal/external carotid artery. A second fluid-filled catheter (PE-10) was advanced 1.5 cm into the femoral artery. ABP waveforms were recorded simultaneously with a BPM-832 Dual Pressure Monitor (CWE Inc.). The ECG was recorded through two leads placed subcutaneously on the left and right chest wall. The signal was amplified (100×) and filtered (10–1,000 Hz) with a differential AC amplifier (AM Systems model 1700). Then, mice stabilized at 1.8% isoflurane for 15 min. ABP and ECG waveforms were digitized (1,000 Hz) with a Micro1401 and Spike2 software. PWV was calculated by the time difference between the upstroke of the carotid versus femoral arterial pressure waves as triggered by the QRS complex of the ECG for 30 consecutive heartbeats. The distance between the carotid and femoral catheter was confirmed postmortem, divided by the carotid-femoral transit time, and reported as meters per second. At the end of experiments, a blood sample (0.2 mL) was collected from the arterial line into a microcentrifuge tube containing heparin (5 U) and centrifuged (10,000 g, 1 min). Plasma electrolytes were assessed with a Medica EasyElectrolyte analyzer (Na+/K+/Cl) (Medica Corporation). All measurements were conducted between 10:00 am and 4:00 pm.

Experiment 3: Assessment of aortic collagen deposition.

Male C57BL/6J mice (n = 6 per group) were randomly assigned and fed 0.1% and 4.0% NaCl diets for 2 wk. Then, 2K1C or sham surgery was performed as described above. At 18–21 days after surgery mice were anesthetized with isoflurane (2–3% in 100% oxygen), whole blood was terminally collected by cardiac puncture and centrifuged, and plasma was stored. Aortas were excised and fixed in 4.0% paraformaldehyde in 10 mM PBS. Tissue was processed in the Research Histology Core at the University of Pittsburgh. Briefly, aortas were paraffin embedded and serially sectioned (5 μm). Sections were stained with Masson’s trichrome (MTC) and were quantitatively evaluated for collagen deposition. Sections from the thoracic aorta were batch processed and imaged by light microscopy. MTC signal was quantified by color thresholding in Fiji, and MTC-positive area was normalized to the total area of the vascular wall.

Experiment 4: Assessment of vascular function in aorta and mesenteric arteries.

Male C57BL/6J mice (n = 8 per group) were randomly assigned and fed 0.1% and 4.0% NaCl diets for 2 wk. Then, 2K1C or sham surgery was performed as described above. At 18–21 days later, mice were anesthetized with isoflurane (2–3% in 100% oxygen). The aortas and mesenteric arteries were rapidly excised, cleaned of fat, and cut into 2-mm rings. Rings were placed on a 2-pin myograph (DMT 620M) filled with physiological salt solution (PSS) containing (in mM) 119 NaCl, 4.7 KCl, 1.17 MgSO4, 1.18 KH2PO4, 5.5 d-glucose, 25 NaHCO3, 0.027 EDTA, and 2.5 CaCl2, pH 7.4 when bubbled with 95% O2-5% CO2 at 37°C. CaCl2 was added once PSS pH reached 7.4. After a 30-min equilibration period, aortas were incrementally stretched to 500-mg initial tension while mesenteric arteries were gradually stretched to a tension corresponding to a transmural pressure of 80 mmHg. Aortic rings were preconstricted with a cumulative dose response to prostaglandin F2α (1 × 10−7 to 1 × 10−5 M) and mesenteric arteries constricted to doses of prostaglandin mimetic U46619 (1 × 10−7 to 5 × 10−7 M). Vessels were washed three times with PSS and allowed to rest for 30 min. A final wash was performed, and vessels rested for an additional 10 min. After the last wash period, aortic rings and mesenteric arteries were constricted with a single dose of prostaglandin F2α (1 × 10−5 M) or U46619 (5 × 10−7 M), respectively. After plateau was reached, a continuous dose-response curve of acetylcholine (1 × 10−8 to 1 × 10−4 M) was used to assess endothelium-dependent relaxation and sodium nitroprusside (1 × 10−9 to 1 × 10−4 M) to assess endothelium-independent relaxation. Ca2+-free PSS containing 1 × 10−6 sodium nitroprusside was added to determine maximal relaxation. Relaxation percentage was normalized by the change in maximal dilation via Ca2+-free PSS. EC50 and Emax values were calculated with GraphPad Prism 8 for each animal from a four-parameter nonlinear regression with variable slope and least-squares regression. Vessels and data were excluded from the analysis if no constriction to KCl was observed. Data reported here represent n = 6 or 7 aorta and n = 5–7 mesenteric vessels.

Statistics.

All data were analyzed with GraphPad Prism v8.0 software. D’Agostino–Pearson tests were performed for normality. Data that passed normality and equal variance tests were analyzed by ANOVA. ABP, PWV, heart rate, renal mass, and plasma electrolytes were compared with a two-way ANOVA (group × diet or diet × time) with repeated measures when appropriate. When significant F values were obtained, post hoc tests were performed with Bonferroni or paired t tests. Vasodilatory responses to acetylcholine and sodium nitroprusside were analyzed by comparing EC50 or Emax values. Values were generated for each animal by curve-fit analysis using a four-parameter, nonlinear regression curve. Data were analyzed using a two-way ANOVA (diet × group) with Bonferroni post hoc test for multiple comparisons. Vasoconstrictor responses were analyzed with a two-way ANOVA with Bonferroni post hoc test for multiple comparisons

Sample sizes were calculated with G*Power (12) and estimated effect sizes from published studies (28, 41). Experiment 1 was designed to detect a ≥10 mmHg change in ABP (α = 0.05, power = 0.9, d = 2; n = 7 or 8 mice/group). Experiment 2 was designed to detect a 1 m/s change in PWV (F test, α = 0.05, power = 0.9, f = 0.7; n = 24 mice, n = 6/group). Experiment 3 was designed to detect a 30% change in collagen deposition (F test, α = 0.05, power = 0.9, f = 0.7; n = 24 mice, n = 6/group). Experiment 4 was designed to detect a 20% change in vessel diameter, which results in a 65% change in vessel flow (F test, α = 0.05, power = 0.9, f = 0.65; n = 28 mice, n = 7/group).

RESULTS

Experiment 1: A high-salt diet acutely exaggerates 2K1C hypertension but chronically increases arterial pulse pressure.

To assess whether a high-salt diet exacerbates ABP in 2K1C hypertension, mice were fed 0.1% and 4.0% NaCl and ABP was assessed by telemetry. No baseline differences in 24-h mean, systolic, or diastolic ABP were observed between mice fed 0.1% and 4.0% NaCl (Fig. 1). After induction of 2K1C hypertension by unilateral placement of a PTFE catheter around the right renal artery (day 0), ABP significantly increased in mice fed 0.1% and 4.0% NaCl (Fig. 1). A two-way ANOVA of mean ABP revealed a significant effect for salt diet (P = 0.003), time (P = 0.001), and interaction (P = 0.035). Post hoc testing indicated that mean ABP of 2K1C mice fed 0.1% versus 4.0% was significantly higher on days 1–7 of 2K1C hypertension (Fig. 1A). However, there was no difference in mean ABP of 2K1C mice fed 0.1% versus 4.0% NaCl diet at days 9–21. Two-way ANOVA of systolic ABP indicated significant effects for salt diet (P = 0.046), time (P < 0.001), and interaction (P = 0.009) (Fig. 1B). Diastolic ABP exhibited similar significant changes due to 2K1C hypertension for time (P < 0.001) and interaction (P < 0.001) but not salt (P = 0.378) (Fig. 1C). Further analysis indicated that the differences in ABP were present during both daytime and nighttime periods (Table 1). Heart rate remained stable throughout the experimental period (Table 1).

Fig. 1.

Fig. 1.

High dietary salt acutely exaggerates 2-kidney, 1-clip (2K1C) hypertension but chronically increases arterial pulse pressure. A–D: means ± SD of 24-h mean arterial blood pressure (ABP) (A), systolic ABP (B), diastolic ABP (C), and arterial pulse pressure (D) of mice fed either 0.1% NaCl or 4.0% NaCl diet (n = 8 per group). 2K1C was induced at day 0. A 2-way ANOVA with repeated-measures analysis (time and diet) followed by Bonferroni t tests assessed group differences. *P < 0.05. E: box plot diagram of kidney mass for 2K1C mice fed either 0.1% NaCl or 4.0% NaCl diet (n = 8 per group). Mass of the contralateral kidney was included for comparison. A 2-way ANOVA with repeated-measures analysis (time and diet) followed by Bonferroni t tests assessed group differences. *P < 0.05.

Table 1.

Daytime and nighttime hemodynamic data of sham-operated and 2K1C mice fed 0.1% or 4.0% NaCl diet at baseline or at days 7 and 20

Daytime
Nighttime
Baseline Day 7 Day 20 Baseline Day 7 Day 20
0.1% NaCl [n = 8 (daytime) and 8 (nighttime)]
Mean ABP, mmHg 97 ± 4 125 ± 6* 124 ± 11* 107 ± 3 140 ± 5* 138 ± 8*
ΔMean ABP, mmHg 0 ± 3 30 ± 8* 18 ± 11* 0 ± 5 34 ± 7* 24 ± 11*
Systolic ABP, mmHg 119 ± 5 152 ± 6* 152 ± 11* 131 ± 4 171 ± 4* 170 ± 8*
Diastolic ABP, mmHg 85 ± 4 112 ± 7* 110 ± 10* 94 ± 3 125 ± 6* 122 ± 9*
Heart rate, beats/min 553 ± 38 526 ± 35 523 ± 36 614 ± 33 594 ± 31 585 ± 22
Pulse pressure 34 ± 1 40 ± 1* 42 ± 1* 37 ± 1 46 ± 2* 49 ± 1*
ΔPulse pressure 0 ± 1 6 ± 4* 5 ± 4* 0 ± 2 9 ± 4* 8 ± 3*
4.0% NaCl [n = 8 (daytime) and 8 (nighttime)]
Mean ABP, mmHg 93 ± 4 136 ± 10*# 121 ± 18* 109 ± 9 150 ± 7*# 137 ± 11*
ΔMean ABP, mmHg 0 ± 4 44 ± 11*# 26 ± 6* 0 ± 4 43 ± 6*# 25 ± 11*
Systolic ABP, mmHg 115 ± 5 165 ± 10*# 154 ± 20* 131 ± 4 182 ± 7*# 174 ± 13*
Diastolic ABP, mmHg 82 ± 3 121 ± 10* 105 ± 15 98 ± 11 133 ± 7*# 119 ± 10*
Heart rate, beats/min 512 ± 14 517 ± 27 507 ± 23 598 ± 15 588 ± 30 562 ± 34
Pulse pressure 33.8 ± 0.7 44.5 ± 0.7* 49.4 ± 1.9*# 33.7 ± 3.1 49.0 ± 0.7* 54.8 ± 1.5*#
ΔPulse pressure 0 ± 2 11 ± 2* 13 ± 8*# 0 ± 8 15 ± 8* 14 ± 7*#

Values are means ± SD for 2-kidney, 1-clip (2K1C) and sham-operated mice. ABP, arterial blood pressure. Two-way ANOVA and Bonferroni post hoc test performed for significance.

*

P < 0.05 from baseline;

#

P < 0.05 between groups.

2K1C mice fed 0.1% and 4.0% NaCl exhibited a time-dependent increase in pulse pressure (systolic ABP − diastolic ABP) (Fig. 1D). A two-way ANOVA revealed a significant effect of salt diet (P = 0.003), time (P < 0.001), and interaction (P < 0.001). Post hoc testing indicated that the magnitude of the increased pulse pressure was significantly greater in mice fed 4.0% NaCl versus 0.1% NaCl at day 9 and throughout the remainder of the experiment. These differences in arterial pulse pressure were present during both daytime and nighttime periods (Table 1). A two-way ANOVA of kidney mass revealed a significant effect of group (P < 0.001) but not diet (P = 0.591) or interaction (P = 0.415). Post hoc comparison indicated that kidney mass of mice fed 0.1% and 4.0% NaCl was significantly lower in clipped versus unclipped kidneys (Fig. 1E). However, there were no differences between mice fed 0.1% and 4.0% NaCl.

Experiment 2: A high-salt diet increases PWV of 2K1C mice.

To assess aortic stiffness, we measured beat-to-beat carotid-femoral PWV of 2K1C or sham-operated mice fed either 4.0% or 0.1% NaCl diet (Fig. 2). Three animals were excluded from the analysis because of blood loss during PWV surgery (n = 2) or death after 2K1C surgery (n = 1). A two-way ANOVA revealed a significant effect for group (P = 0.004), salt diet (P = 0.036), and interaction (P = 0.001). Post hoc testing revealed a significant elevation in PWV of 2K1C mice fed 4.0% NaCl versus sham-operated mice fed 4.0% NaCl and 2K1C mice fed 0.1% NaCl (Fig. 2). No significant differences were found between sham-operated mice fed 0.1% versus 4.0% NaCl diet or sham-operated versus 2K1C mice fed 0.1% NaCl.

Fig. 2.

Fig. 2.

A high-salt diet increases pulse pressure wave velocity (PWV) of 2-kidney, 1-clip (2K1C) mice: box plot diagrams of PWV (A), mean arterial blood pressure (MAP) (B), heart rate [C, beats/min (bpm)], and right kidney mass (D) in sham-operated and 2K1C mice fed either 0.1% NaCl or 4.0% NaCl diet (n = 7 or 8 per group). Data were analyzed by a 2-way ANOVA (condition and diet) followed by Bonferroni post hoc test. *P < 0.05.

A two-way ANOVA of mean ABP revealed a significant effect of group (P < 0.0004) but not salt diet (P = 0.742) or interaction (P = 0.980). Mean ABP of 2K1C mice was higher than mean ABP of sham-operated mice; however, there were no differences in mean ABP between 2K1C mice fed 0.1% versus 4.0% NaCl (Fig. 2B). A two-way ANOVA of heart rate revealed no significant effect of group (P = 0.931), salt diet (P = 0.405), and interaction (P = 0.942) (Fig. 2C). A two-way ANOVA of renal mass indicated a significant effect for group (P < 0.001) but not salt diet (P = 0.504) or interaction (P = 0.414). Post hoc testing further revealed significant reductions in renal mass of 2K1C mice fed 0.1% NaCl and 4.0% NaCl versus sham-operated groups (Fig. 2D). Two-way ANOVAs revealed no significant differences in body weight or plasma electrolyte concentrations across groups (Table 2).

Table 2.

Body weight and plasma electrolyte data of sham-operated and 2K1C mice fed 0.1% or 4.0% NaCl diet

Sham, 0.1% 2K1C, 0.1% Sham, 4.0% 2K1C, 4.0%
n 7 8 7 7
Body weight, g 24.9 ± 2.7 23.5 ± 2.2 25.5 ± 3.5 23.9 ± 2.1
Na+, mM 145.7 ± 3.0 145.8 ± 3.3 144.5 ± 2.1 144.6 ± 1.8
K+, mM 4.17 ± 0.49 3.73 ± 0.32 4.86 ± 0.76 4.52 ± 0.30
Cl, mM 118.0 ± 6.0 116.6 ± 3.4 117.8 ± 2.3 117.8 ± 2.8

Values are means ± SD for 2-kidney, 1-clip (2K1C) and sham-operated (Sham) mice. A 2-way ANOVA was performed for statistical significance.

Experiment 3. Histological assessment of aortic collagen deposition reveals no differences across groups.

Aortas collected from a third cohort of mice were histologically assessed for increased collagen deposition typically associated with aortic fibrosis. Figure 3 illustrates representative examples of aortas processed with Masson’s trichrome staining. Quantification of collagen-positive area and two-way ANOVA did not reveal any significant differences for group (P = 0.407), salt diet (P = 0.166), and interaction (P = 0.132).

Fig. 3.

Fig. 3.

Histological assessment of aortas from 2-kidney, 1-clip (2K1C) mice. Left: Masson’s trichrome staining of transverse aortic sections from sham-operated or 2K1C mice fed 0.1% NaCl or 4.0% NaCl. Asterisks indicate lumen. Scale bars, 200 μm. Right: means ± SD of normalized collagen-positive area. A 2-way ANOVA (group × diet) revealed no significant differences across groups. a.u., Arbitrary units.

Experiment 4: High-salt diet impairs endothelium-dependent vasodilation in the aorta but not mesenteric arteries of 2K1C mice.

Endothelial function is a key modulator of conduit artery and resistance artery function. Thus, we assessed both endothelium-dependent and -independent vasodilation in aortas of sham-operated and 2K1C mice fed 0.1% NaCl or 4.0% NaCl diet. Endothelium-dependent vasodilation was assessed to increasing concentrations of acetylcholine (1 × 10−8 to 1 × 10−4 M). Figure 4, A and B, plot the aorta relaxation responses to acetylcholine and sodium nitroprusside, respectively. The curves were compared by calculating the EC50 and Emax. A two-way ANOVA of acetylcholine EC50 indicated a significant effect for group (P = 0.009), diet (P = 0.006), and interaction (P = 0.010) (Fig. 4C). Post hoc testing revealed a significant increase in the acetylcholine EC50 of 2K1C mice fed 4.0% NaCl versus sham-operated mice fed 0.1% NaCl, sham-operated mice fed 4.0% NaCl, and 2K1C mice fed 0.1% NaCl. Furthermore, a two-way ANOVA of acetylcholine Emax revealed a significant effect for group (P = 0.001) but not diet (P = 0.0744) or interaction (P = 0.308). Post hoc testing indicated that 2K1C mice fed 4.0% NaCl had a significantly lower Emax than 2K1C mice fed 0.1% NaCl or sham-operated mice fed 0.1% or 4.0% NaCl (Fig. 4D). Two-way ANOVAs for sodium nitroprusside EC50 or Emax of aorta revealed no significant differences for diet (P > 0.3), group (P > 0.5), or interaction (P > 0.2) (data not shown).

Fig. 4.

Fig. 4.

Aortic endothelium-dependent vasodilation is impaired in 2-kidney, 1-clip (2K1C) mice fed high-salt diet. A and B: mean ± SD % relaxation in response to acetylcholine (A) or sodium nitroprusside (SNP) (B) of aortae from sham-operated or 2K1C mice fed 0.1% or 4.0% NaCl (n = 6 or 7 per group). C and D: box plot diagrams of EC50 (C) and Emax (D) of acetylcholine vasodilatory responses. A 2-way ANOVA with Bonferroni post hoc test for multiple comparisons revealed significant differences between groups including a higher EC50 but lower Emax of 2K1C mice fed 4.0% NaCl. *P < 0.05.

Figure 5 illustrates vasodilatory responses of third-order mesenteric arteries to acetylcholine and sodium nitroprusside. The curves were compared by calculating the EC50 and Emax. A two-way ANOVA for acetylcholine EC50 indicated no significant differences for diet (P = 0.884), group (P = 0.162), or interaction (P = 0.699) and no significant differences in Emax for diet (P = 0.494), group (P = 0.602), or interaction (P = 0.385) (Fig. 5, C and D). In addition, a two-way ANOVA for sodium nitroprusside EC50 indicated no significant differences for diet (P = 0.159), group (0.769), or interaction (P = 0.892) and no differences in Emax for diet (P = 0.641), group (0.252), or interaction (P = 0.645) (data not shown).

Fig. 5.

Fig. 5.

Endothelial function of mesenteric resistance arteries was not impaired by a high-salt diet or 2-kidney, 1-clip (2K1C) hypertension. A and B: mean ± SD % relaxation in response to acetylcholine (A) or sodium nitroprusside (SNP) (B) of mesenteric resistance arteries from sham-operated or 2K1C mice fed 0.1% or 4.0% NaCl (n = 6 or 7 per group). C and D: box plot diagrams of EC50 (C) and Emax (D) of acetylcholine vasodilatory responses. A 2-way ANOVA revealed no significant differences between groups.

Finally, vasoconstriction responses to KCl administration were assessed in both aorta and mesenteric arteries (Fig. 6). A two-way ANOVA of aortic response revealed a significant main effect for dietary salt (P = 0.040) but not group (P = 0.618) or interaction (P = 0.076). Post hoc testing further revealed a significant elevation in vasoconstriction responses between 4.0% NaCl-fed 2K1C mice and 0.1% NaCl-fed 2K1C control mice (Fig. 6A). A two-way ANOVA of mesenteric responses to KCl revealed no significant differences for dietary salt (P = 0.546), group (P = 0.284), or interaction (P = 0.810) (Fig. 6B).

Fig. 6.

Fig. 6.

Aortic vasoconstriction is enhanced in 2-kidney, 1-clip (2K1C) mice fed a high-salt diet: box plot diagrams of aortic (A) and mesenteric (B) vasoconstriction responses to bath application of KCl (n = 6–8 per group). A 2-way ANOVA with Bonferroni post hoc test for multiple comparisons revealed a significantly greater vasoconstriction of the aorta in 2K1C mice fed 4.0% NaCl vs. other groups. *P < 0.05.

DISCUSSION

The present study tested whether a murine 2K1C model of renovascular hypertension exhibits salt sensitivity and vascular dysfunction. Twenty-four-hour telemetry-based recordings of ABP indicate that a high-salt diet transiently exaggerated 2K1C renovascular hypertension. Unexpectedly, arterial pulse pressure increased more in 2K1C mice fed 4.0% versus 0.1% NaCl. PWV measurements confirmed the presence of aortic stiffness in 2K1C mice fed 4.0% but not 0.1% NaCl or sham-operated mice. Interestingly, 2K1C mice fed 4.0% NaCl exhibited a reduced endothelium-dependent vasodilation in the aorta but not in mesenteric resistance arteries. These findings demonstrate that a high-salt diet transiently exaggerates 2K1C renovascular hypertension but chronically promotes aortic stiffness and selective vascular dysfunction.

A high-salt diet contributes to or exaggerates hypertension in many experimental models (19, 2123, 25, 28, 38). Although previous studies have explored the impact of dietary salt in the 2K1C model, these investigations used tail-cuff measurements, implemented high-salt feeding at the time of or after clipping, and largely relied on single time points for ABP measurements (10, 15, 34, 35, 51). Here, telemetry-based recordings indicate no baseline differences in ABP between mice fed 0.1% and 4.0% NaCl. These observations are consistent with published studies examining the effect of salt diet on ABP in standard laboratory rodent strains regarded as salt resistant (27, 28, 54, 56). Despite the lack of differences in baseline ABP of mice fed 0.1% versus 4.0% NaCl, the mechanisms supporting ABP such as cardiac output or total peripheral resistance could differ between groups. The NaCl content of the diet was chosen to allow direct comparisons to prior studies of salt-sensitive hypertension in rodents (19, 2123, 25, 28, 38), but we acknowledge that a limitation is whether this level of dietary salt reflects human salt consumption.

Despite the lack of differences in baseline ABP of mice fed 0.1% and 4.0% NaCl, a high-salt diet transiently exaggerated 2K1C hypertension during the first 7 days, and ABP normalized thereafter. Other studies report a similar time course or no differences in ABP between high- and low-NaCl groups (10, 15, 45, 49, 51). The mechanism(s) by which a high-salt diet transiently exaggerates ABP in 2K1C mice is not known but may include a higher cardiac output due to the dietary salt loading, enhanced cardiovascular reactivity by high salt to surgical stress, or an interaction between high salt and RAAS. The development of experimental renovascular hypertension is strongly linked with activation of RAAS (6, 7, 48). This is supported by evidence in which plasma renin activity and angiotensin II levels sharply increase in parallel with ABP immediately after renal artery clipping in 2K1C models (7, 52, 63). RAAS dependence of 2K1C hypertension is further substantiated by significant ABP-lowering effects of renin antibodies or converting enzyme inhibitors administered during the early phase of 2K1C ABP elevation (<2 wk after 2K1C induction) but not the chronic phase that is less sensitive to RAAS inhibition (36, 48). Thus, the exaggerated ABP over the initial 7 days may reflect an interaction between dietary salt and activation of the RAAS.

Surprisingly, a high-salt diet did not produce a sustained salt-sensitive phenotype in 2K1C hypertension. This chronic phase of 2K1C renovascular hypertension is attributed to a small activation of the RAAS and sympathoexcitation (5, 24, 37). A high-salt diet, by itself, sensitizes sympathetic circuits and exaggerates sympathetic reflex responses (54, 55). Furthermore, multiple models of neurogenic hypertension are salt sensitive (19, 2123, 25, 28, 38), and we therefore expected the chronic phase of 2K1C hypertension to demonstrate a salt sensitivity. The lack of a sustained salt-sensitive hypertension may reflect a compensatory pressure natriuresis or attenuated RAAS activation in the chronic phase of 2K1C hypertension, but these mechanisms remain to be specifically tested.

An unexpected finding in the present study was the greater increase in arterial pulse pressure and aortic stiffness of 2K1C mice fed 4.0% NaCl versus 0.1% NaCl. This finding was independent of ABP but could be a consequence of other factors (e.g., increased stroke volume). The greatest difference in pulse pressure occurred at day 21 when ABP between groups was similar. Carotid-femoral PWV measurements confirmed the presence of increased aortic stiffness in 2K1C mice fed 4.0% but not 0.1% NaCl. To our knowledge, these findings represent the first report of a novel interaction between renal artery stenosis and dietary salt to promote aortic stiffness. PWV measurements are sensitive to both vascular wall distension and the level of ABP. Surprisingly, 2K1C mice fed 0.1% NaCl did not have an elevated PWV versus sham-operated mice fed 0.1% NaCl. The reason for the lack of a difference is unclear. Nevertheless, our findings are clinically important, as increased aortic stiffness is a predictor of future cardiovascular and total mortality (29, 58) and a determinant of renal microvascular damage (14, 50). Aortic pulse pressure and carotid-femoral PWV positively correlated with increased renal resistivity index (measure of altered pulsatile flow-velocity waveform in the renal artery) in hypertensive patients independently of elevated ABP (17, 47). Similarly, a longitudinal study reported that arterial stiffness was significantly elevated in patients with refractory atherosclerotic renovascular hypertension compared with essential hypertensive patients (13). Altogether, the above evidence suggests that dietary salt loading may promote a unique interaction between renovascular hypertension and vascular function.

Both arterial pulse pressure and carotid-femoral PWV measurements indicate that dietary salt and renovascular hypertension promote conduit vessel dysfunction. Using myography, we observed a significant impairment in endothelium-dependent, but not endothelium-independent, vasodilation in the aorta of 2K1C mice fed 4.0% NaCl. Surprisingly, the impaired endothelial function was specific for the aortae of 2K1C mice fed high salt, as both vasodilatory responses to acetylcholine and sodium nitroprusside in mesenteric arteries were unchanged. An explanation for blunted aortic vasodilation is reduced nitric oxide bioavailability due to impaired endothelial nitric oxide synthase activity in 2K1C mice fed high-salt diet or increased superoxide levels from NADPH oxidase or mitochondria uncoupling (20, 40). High-salt diet alone reduces endothelial nitric oxide synthase expression and activity in both aortae and endothelial cells (31, 39). Moreover, reduced nitric oxide bioavailability due to high-salt feeding was also found to be independent of elevated ABP (4). Overexpression of endothelial nitric oxide synthase blunts the increase in ABP elevation due to 2K1C hypertension (16). Thus, endothelial nitric oxide synthase activity may play an important role in modulating endothelial function in 2K1C hypertension and may explain the blunted endothelium-dependent vasodilation in conduit arteries of 2K1C mice fed 4.0% NaCl diet. Future studies are needed to determine the mechanism causing endothelial dysfunction in this model.

A second potential mechanism for the impaired vasodilatory responses is due to bradykinin. Bradykinin influences endothelial nitric oxide synthase activity and renovascular hypertension (2, 33, 53). Pharmacological blockade of the bradykinin-2 receptor in combination with high-salt diet synergistically and negatively influenced conduit artery remodeling (46). Deletion of the bradykinin-2 receptor accelerates and exacerbates 2K1C hypertension, thereby suggesting that bradykinin promotes vascular homeostasis when ABP is elevated (8, 33). Moreover, NG-nitro-l-arginine methyl ester (l-NAME) administration failed to increase ABP in bradykinin-2 receptor-deficient mice with renovascular hypertension (8). Future studies should investigate whether a high-salt diet impacts bradykinin levels or bradykinin-2 receptor expression in 2K1C hypertension.

Collectively, our data suggest that the murine 2K1C model exhibits a transient salt-sensitive hypertension during the initial week when peak activation of the RAAS occurs. Unexpectedly, we also found that a high-salt diet plus 2K1C hypertension produced a time-dependent and progressive increase in aortic pulse pressure due to aortic stiffness and impaired endothelial function in conduit vessels. Surprisingly, this effect was specific to the aorta, as mesenteric resistance artery function was preserved. The mechanism supporting the synergistic impact remains to be elucidated. However, this model may represent a unique approach to study hypertensive cardiovascular disease in the absence of peripheral vascular endothelial dysfunction. The findings also highlight potential issues regarding interrogations using aortic rings to reflect changes in vascular function of resistance vessels.

GRANTS

The research was supported by National Institutes of Health Grants R01-HL-145875 (to S. D. Stocker), R01-HL-128388 (to S. D. Stocker and W. B. Farquhar), R01-HL-128304 (to A. C. Straub), and F32-DK-123994 (to L. J. DeLalio).

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the authors.

AUTHOR CONTRIBUTIONS

L.J.D., A.C.S., and S.D.S. conceived and designed research; L.J.D., S.A.H., and S.D.S. performed experiments; L.J.D., S.A.H., P.L.K., and S.D.S. analyzed data; L.J.D., A.C.S., and S.D.S. interpreted results of experiments; L.J.D. prepared figures; L.J.D. drafted manuscript; L.J.D., S.A.H., P.L.K., M.M.W., W.B.F., A.C.S., and S.D.S. edited and revised manuscript; L.J.D., P.L.K., M.M.W., W.B.F., A.C.S., and S.D.S. approved final version of manuscript.

ACKNOWLEDGMENTS

We thank the University of Pittsburgh Research Histology Core for all tissue processing and histological staining.

REFERENCES

  • 1.Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 123: 1138–1143, 2011. doi: 10.1161/CIR.0b013e31820d0793. [DOI] [PubMed] [Google Scholar]
  • 2.Bao G, Gohlke P, Unger T. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol 20, Suppl 9: S96–S99, 1992. doi: 10.1097/00005344-199200209-00017. [DOI] [PubMed] [Google Scholar]
  • 3.Benjamin MM, Fazel P, Filardo G, Choi JW, Stoler RC. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol 113: 687–690, 2014. doi: 10.1016/j.amjcard.2013.10.046. [DOI] [PubMed] [Google Scholar]
  • 4.Boegehold MA. The effect of high salt intake on endothelial function: reduced vascular nitric oxide in the absence of hypertension. J Vasc Res 50: 458–467, 2013. doi: 10.1159/000355270. [DOI] [PubMed] [Google Scholar]
  • 5.Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 159: 438–448, 2010. doi: 10.1111/j.1476-5381.2009.00546.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Červenka L, Horácek V, Vanecková I, Hubácek JA, Oliverio MI, Coffman TM, Navar LG. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 40: 735–741, 2002. doi: 10.1161/01.HYP.0000036452.28493.74. [DOI] [PubMed] [Google Scholar]
  • 7.Červenka L, Vanecková I, Husková Z, Vanourková Z, Erbanová M, Thumová M, Skaroupková P, Opocenský M, Malý J, Chábová VČ, Tesař V, Bürgelová M, Viklický O, Teplan V, Zelízko M, Kramer HJ, Navar LG. Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens 26: 1379–1389, 2008. doi: 10.1097/HJH.0b013e3282fe6eaa. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Červenka L, Vanecková I, Malý J, Horácek V, El-Dahr SS. Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J Hypertens 21: 1531–1538, 2003. doi: 10.1097/00004872-200308000-00018. [DOI] [PubMed] [Google Scholar]
  • 9.de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 27: 1333–1340, 2009. doi: 10.1097/HJH.0b013e328329bbf4. [DOI] [PubMed] [Google Scholar]
  • 10.de Simone G, Devereux RB, Camargo MJ, Wallerson DC, Laragh JH. Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension. Am J Physiol Heart Circ Physiol 264: H2103–H2110, 1993. doi: 10.1152/ajpheart.1993.264.6.H2103. [DOI] [PubMed] [Google Scholar]
  • 11.Faber JE, Brody MJ. Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats. Hypertension 5: I155–I164, 1983. doi: 10.1161/01.HYP.5.2_Pt_2.I155. [DOI] [PubMed] [Google Scholar]
  • 12.Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175–191, 2007. doi: 10.3758/BF03193146. [DOI] [PubMed] [Google Scholar]
  • 13.Fodor L, Premužić V, Ivković V, Perkov D, Laganović M, Vrkić TŽ, Dika Z, Živko M, Jelaković B. Arterial stiffness in atherosclerotic renovascular hypertension. J Hypertens 32: 2238–2245, 2014. doi: 10.1097/HJH.0000000000000324. [DOI] [PubMed] [Google Scholar]
  • 14.Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 55: 1110–1115, 2010. doi: 10.1161/HYPERTENSIONAHA.109.143024. [DOI] [PubMed] [Google Scholar]
  • 15.Gallo A, Taquini CM, Fontán M, Campissi R, Kuraja I, Gomez Llambí H, Taquini AC. Sodium intake modulates the development of cardiac hypertrophy in two-kidney, one clip rats. Hypertension 15, Suppl: I157–I160, 1990. doi: 10.1161/01.HYP.15.2_Suppl.I157. [DOI] [PubMed] [Google Scholar]
  • 16.Gava AL, Peotta VA, Cabral AM, Vasquez EC, Meyrelles SS. Overexpression of eNOS prevents the development of renovascular hypertension in mice. Can J Physiol Pharmacol 86: 458–464, 2008. doi: 10.1139/Y08-044. [DOI] [PubMed] [Google Scholar]
  • 17.Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension 58: 839–846, 2011. doi: 10.1161/HYPERTENSIONAHA.111.177469. [DOI] [PubMed] [Google Scholar]
  • 18.Haywood JR, Buggy J, Fink GD, DiBona GF, Johnson AK, Brody MJ. Alterations in cerebrospinal fluid sodium and osmolality in rats during one-kidney, one-wrap renal hypertension. Clin Exp Pharmacol Physiol 11: 545–549, 1984. doi: 10.1111/j.1440-1681.1984.tb00865.x. [DOI] [PubMed] [Google Scholar]
  • 19.Haywood JR, Williams SF, Ball NA. Contribution of sodium to the mechanism of one-kidney, renal-wrap hypertension. Am J Physiol Heart Circ Physiol 247: H797–H803, 1984. doi: 10.1152/ajpheart.1984.247.5.H797. [DOI] [PubMed] [Google Scholar]
  • 20.Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Bräsen JH, Meinertz T, Münzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252–260, 1999. doi: 10.1046/j.1523-1755.1999.00229.x. [DOI] [PubMed] [Google Scholar]
  • 21.Hildebrandt DA, Irwin ED, Lohmeier TE. Prolonged baroreflex activation abolishes salt-induced hypertension after reductions in kidney mass. Hypertension 68: 1400–1406, 2016. doi: 10.1161/HYPERTENSIONAHA.116.08293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Huang BS, Van Vliet BN, Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 287: H1160–H1166, 2004. doi: 10.1152/ajpheart.00126.2004. [DOI] [PubMed] [Google Scholar]
  • 23.Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 289: H1519–H1529, 2005. doi: 10.1152/ajpheart.00206.2005. [DOI] [PubMed] [Google Scholar]
  • 24.Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, Friberg P. Increased sympathetic nerve activity in renovascular hypertension. Circulation 99: 2537–2542, 1999. doi: 10.1161/01.CIR.99.19.2537. [DOI] [PubMed] [Google Scholar]
  • 25.Kandlikar SS, Fink GD. Mild DOCA-salt hypertension: sympathetic system and role of renal nerves. Am J Physiol Heart Circ Physiol 300: H1781–H1787, 2011. doi: 10.1152/ajpheart.00972.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kashyap S, Boyilla R, Zaia PJ, Ghossan R, Nath KA, Textor SC, Lerman LO, Grande JP. Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent. Res Vet Sci 107: 171–177, 2016. doi: 10.1016/j.rvsc.2016.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kim SM, Eisner C, Faulhaber-Walter R, Mizel D, Wall SM, Briggs JP, Schnermann J. Salt sensitivity of blood pressure in NKCC1-deficient mice. Am J Physiol Renal Physiol 295: F1230–F1238, 2008. doi: 10.1152/ajprenal.90392.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547–556, 2007. doi: 10.1161/HYPERTENSIONAHA.107.090696. [DOI] [PubMed] [Google Scholar]
  • 29.Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236–1241, 2001. doi: 10.1161/01.HYP.37.5.1236. [DOI] [PubMed] [Google Scholar]
  • 30.Leenen FH, Ruzicka M, Huang BS. The brain and salt-sensitive hypertension. Curr Hypertens Rep 4: 129–135, 2002. doi: 10.1007/s11906-002-0037-y. [DOI] [PubMed] [Google Scholar]
  • 31.Li J, White J, Guo L, Zhao X, Wang J, Smart EJ, Li XA. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 139: 447–451, 2009. doi: 10.3945/jn.108.097451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liard JF, Cowley AW Jr, McCaa RE, McCaa CS, Guyton AC. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res 34: 549–560, 1974. doi: 10.1161/01.RES.34.4.549. [DOI] [PubMed] [Google Scholar]
  • 33.Madeddu P, Milia AF, Salis MB, Gaspa L, Gross W, Lippoldt A, Emanueli C. Renovascular hypertension in bradykinin B2-receptor knockout mice. Hypertension 32: 503–509, 1998. doi: 10.1161/01.HYP.32.3.503. [DOI] [PubMed] [Google Scholar]
  • 34.Möhring J, Petri M, Szokol M, Haack D, Möhring B. Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol 230: 849–857, 1976. doi: 10.1152/ajplegacy.1976.230.3.849. [DOI] [PubMed] [Google Scholar]
  • 35.Morgan T, Aubert JF, Brunner H. Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy. Am J Hypertens 14: 914–920, 2001. doi: 10.1016/S0895-7061(01)02135-5. [DOI] [PubMed] [Google Scholar]
  • 36.Morton JJ, Wallace EC. The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat. Clin Sci (Lond) 64: 359–370, 1983. doi: 10.1042/cs0640359. [DOI] [PubMed] [Google Scholar]
  • 37.Nakada T, Kubota Y, Suzuki H, Sasagawa I, Watanabe M, Ishigooka M. Suppression of sympathetic nervous system attenuates the development of two-kidney, one-clip Goldblatt hypertension. J Urol 156: 1480–1484, 1996. doi: 10.1016/S0022-5347(01)65634-9. [DOI] [PubMed] [Google Scholar]
  • 38.Nakamura K, Cowley AW Jr. Sequential changes of cerebrospinal fluid sodium during the development of hypertension in Dahl rats. Hypertension 13: 243–249, 1989. doi: 10.1161/01.HYP.13.3.243. [DOI] [PubMed] [Google Scholar]
  • 39.Ni Z, Vaziri ND. Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens 14: 155–163, 2001. doi: 10.1016/S0895-7061(00)01234-6. [DOI] [PubMed] [Google Scholar]
  • 40.Oliveira-Sales EB, Dugaich AP, Abreu NP, Carillo BA, Boim MA, Bergamaschi CT, Campos RR. Oxidative stress supports blood pressure and sympathetic activity in renovascular hypertension (Abstract) FASEB J 20: A737, 2006. [Google Scholar]
  • 41.Ong J, Kinsman BJ, Sved AF, Rush BM, Tan RJ, Carattino MD, Stocker SD. Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice. J Neurophysiol 122: 358–367, 2019. doi: 10.1152/jn.00173.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Oparil S, Sripairojthikoon W, Wyss JM. The renal afferent nerves in the pathogenesis of hypertension. Can J Physiol Pharmacol 65: 1548–1558, 1987. doi: 10.1139/y87-244. [DOI] [PubMed] [Google Scholar]
  • 43.Osborn JW, Fink GD. Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol 95: 61–68, 2010. doi: 10.1113/expphysiol.2008.046326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228–235, 2007. doi: 10.1007/s11906-007-0041-3. [DOI] [PubMed] [Google Scholar]
  • 45.Özaykan B, Doğan A. Effects of salt loading on sympathetic activity and blood pressure in anesthetized two-kidney, one clip hypertensive rats. Bosn J Basic Med Sci 11: 228–233, 2011. doi: 10.17305/bjbms.2011.2555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Partovian C, Benetos A, Pommiès JP, Mischler W, Safar ME. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol Heart Circ Physiol 274: H1423–H1428, 1998. doi: 10.1152/ajpheart.1998.274.5.H1423. [DOI] [PubMed] [Google Scholar]
  • 47.Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344: 410–417, 2001. doi: 10.1056/NEJM200102083440603. [DOI] [PubMed] [Google Scholar]
  • 48.Romero JC, Hoobler SW, Kozak TJ, Warzynski RJ. Effect of antirenin on blood pressure of rabbits with experimental renal hypertension. Am J Physiol 225: 810–817, 1973. doi: 10.1152/ajplegacy.1973.225.4.810. [DOI] [PubMed] [Google Scholar]
  • 49.Romero JC, Holmes DR, Strong CG. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery. Circ Res 40, Suppl 1: I17–I23, 1977. [PubMed] [Google Scholar]
  • 50.Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 43: 163–168, 2004. doi: 10.1161/01.HYP.0000114571.75762.b0. [DOI] [PubMed] [Google Scholar]
  • 51.Sato Y, Ando K, Ogata E, Fujita T. Salt sensitivity in Goldblatt hypertensive rats—role of extracellular fluid volume and renin-angiotensin system. Jpn Circ J 55: 165–173, 1991. doi: 10.1253/jcj.55.165. [DOI] [PubMed] [Google Scholar]
  • 52.Schricker K, Holmer S, Krämer BK, Riegger G, Kurtz A. Control of renin gene expression in 2 kidney-1 clip rats. Kidney Int 46: 1539–1541, 1994. doi: 10.1038/ki.1994.440. [DOI] [PubMed] [Google Scholar]
  • 53.Sharma JN. Hypertension and the bradykinin system. Curr Hypertens Rep 11: 178–181, 2009. doi: 10.1007/s11906-009-0032-7. [DOI] [PubMed] [Google Scholar]
  • 54.Simmonds SS, Lay J, Stocker SD. Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats. Hypertension 64: 583–589, 2014. doi: 10.1161/HYPERTENSIONAHA.114.03250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Stocker SD, Madden CJ, Sved AF. Excess dietary salt intake alters the excitability of central sympathetic networks. Physiol Behav 100: 519–524, 2010. doi: 10.1016/j.physbeh.2010.04.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46: 326–332, 2005. doi: 10.1161/01.HYP.0000175474.99326.bf. [DOI] [PubMed] [Google Scholar]
  • 57.Toney GM, Stocker SD. Hyperosmotic activation of CNS sympathetic drive: implications for cardiovascular disease. J Physiol 588: 3375–3384, 2010. doi: 10.1113/jphysiol.2010.191940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55: 1318–1327, 2010. doi: 10.1016/j.jacc.2009.10.061. [DOI] [PubMed] [Google Scholar]
  • 59.Warner GM, Cheng J, Knudsen BE, Gray CE, Deibel A, Juskewitch JE, Lerman LO, Textor SC, Nath KA, Grande JP. Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol 302: F1455–F1464, 2012. doi: 10.1152/ajprenal.00645.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Weber BR, Dieter RS. Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis 7: 169–181, 2014. doi: 10.2147/IJNRD.S40175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 8: 166–170, 2006. doi: 10.1007/s11906-006-0014-y. [DOI] [PubMed] [Google Scholar]
  • 62.Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481–490, 1996. doi: 10.1161/01.HYP.27.3.481. [DOI] [PubMed] [Google Scholar]
  • 63.Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29: 1025–1030, 1997. doi: 10.1161/01.HYP.29.4.1025. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Heart and Circulatory Physiology are provided here courtesy of American Physiological Society

RESOURCES